News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
391,224 Results
Type
Article (26752)
Company Profile (117)
Press Release (364355)
Section
Business (101903)
Career Advice (533)
Deals (17966)
Drug Delivery (79)
Drug Development (38678)
Employer Resources (78)
FDA (10687)
Job Trends (9968)
News (175112)
Policy (20599)
Tag
Academia (2102)
Alliances (28394)
Alzheimer's disease (822)
Approvals (10687)
Artificial intelligence (115)
Bankruptcy (144)
Best Places to Work (8952)
Biotechnology (64)
Breast cancer (106)
Cancer (691)
Cardiovascular disease (73)
Career advice (489)
Cell therapy (127)
Clinical research (31248)
Collaboration (301)
COVID-19 (2148)
C-suite (63)
Data (831)
Diabetes (113)
Diagnostics (4743)
Drug pricing (85)
Earnings (33191)
Employer resources (69)
Events (71267)
Executive appointments (254)
FDA (11156)
Funding (291)
Gene therapy (93)
GLP-1 (335)
Government (4072)
Healthcare (14884)
Infectious disease (2230)
Inflammatory bowel disease (75)
IPO (7642)
Job creations (1404)
Job search strategy (447)
Layoffs (153)
Legal (3886)
Lung cancer (94)
Manufacturing (115)
Medical device (9254)
Medtech (9257)
Mergers & acquisitions (10448)
Metabolic disorders (303)
Neuroscience (1000)
NextGen Class of 2024 (4970)
Non-profit (3918)
Northern California (956)
Obesity (183)
Opinion (107)
People (32114)
Phase I (9936)
Phase II (12249)
Phase III (11135)
Pipeline (296)
Policy (59)
Postmarket research (1573)
Preclinical (3158)
Radiopharmaceuticals (147)
Rare diseases (169)
Real estate (2835)
Regulatory (13620)
Research institute (1905)
Southern California (759)
Startups (2079)
United States (9249)
Vaccines (453)
Weight loss (115)
Date
Today (76)
Last 7 days (350)
Last 30 days (1655)
Last 365 days (21806)
2024 (21485)
2023 (24258)
2022 (33693)
2021 (37134)
2020 (37571)
2019 (33256)
2018 (24881)
2017 (17708)
2016 (18859)
2015 (21431)
2014 (16060)
2013 (12721)
2012 (13464)
2011 (13906)
2010 (11929)
Location
Africa (510)
Arizona (95)
Asia (21155)
Australia (3791)
California (2051)
Canada (937)
China (173)
Colorado (112)
Connecticut (137)
Europe (47166)
Florida (323)
Georgia (109)
Illinois (263)
Indiana (198)
Japan (59)
Kansas (72)
Maine (59)
Maryland (431)
Massachusetts (1674)
Michigan (106)
Minnesota (155)
New Jersey (764)
New York (666)
North Carolina (504)
Northern California (956)
Ohio (93)
Pennsylvania (599)
South America (669)
Southern California (759)
Texas (282)
Utah (87)
Washington State (277)
391,224 Results for "jaguar health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FDA Approves Orphan-Drug Designation for Jaguar Health’s Crofelemer for Treatment of Diarrhea in Cholera
December 17, 2024
·
8 min read
Deals
Jaguar Health Regains Compliance with Nasdaq’s Bid Price Requirement - June 26, 2024
Jaguar Health, Inc. today announced that on June 25, 2024 the Company received formal notice from The Nasdaq Stock Market LLC that Jaguar has regained compliance with Nasdaq’s minimum bid price requirement.
June 26, 2024
·
3 min read
Biotech Bay
Jaguar Health Reports Approval of All Proposals at June 2024 Annual Meeting of Stockholders
Jaguar Health, Inc. announced the voting results of the Company’s Annual Meeting of Stockholders held June 21, 2024.
June 21, 2024
·
4 min read
Business
Jaguar Health Reports First Quarter 2024 Financial Results
Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”) today reported consolidated first-quarter 2024 financial results and provided Company updates.
May 14, 2024
·
14 min read
Press Releases
Jaguar Health Reports Third Quarter 2024 Financial Results
November 13, 2024
·
13 min read
Business
Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International
Jaguar Health, Inc. today announced that Massimo Radaelli, PhD, has been appointed President of Jaguar International.
April 2, 2024
·
7 min read
Business
Jaguar Health Executes Out-License Deal with Joint Venture Magdalena Biosciences for Botanical Drug Candidate for Schizophrenia
Jaguar Health, Inc. today announced that the company’s out-licensing agreement with Magdalena Biosciences, Inc. (“Magdalena”), the joint venture formed by Jaguar and Filament Health Corp.
May 29, 2024
·
9 min read
Business
Jaguar Health Reports 2023 Financial Results
Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”) today reported consolidated financial results for the year ended December 31, 2023.
April 1, 2024
·
12 min read
Press Releases
U.S. Investigator-Initiated Trial (IIT) to Evaluate Jaguar Health’s Crofelemer for Short Bowel Syndrome with Intestinal Failure (SBS-IF) Begins
December 6, 2024
·
6 min read
Press Releases
Ladenburg Thalmann to Host Scientific Showcase December 18, 2024 About Rare Disease Clinical Development Efforts for Jaguar Health’s Crofelemer
December 16, 2024
·
4 min read
1 of 39,123
Next
